STAT April 25, 2024
Adam Feuerstein

This is the online edition of Adam’s Biotech Scorecard, a new subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered every Thursday to their inbox.

Last night, we held our 2024 STATUS List dinner, honoring 50 influential people shaping the future of health, medicine and life sciences. It was an amazing evening, and a chance to eat and chat with some brilliant and engaging honorees. At dinner, to my left, was Biogen CEO Chris Viehbacher; to my right, Avoro Capital’s Behzad...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech
Akiko Iwasaki: The Immunology of Covid and the Future
Novartis to acquire radiopharmaceutical firm Mariana Oncology for up to $1.75B
GLP-1 Agonists May One Day Treat Prostate Cancer
Amgen shares soar as executives outline obesity drug push
BridgeBio, Ipsen, George Medicines and more—Chutes & Ladders

Share This Article